Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
fda
3
×
life sciences
national blog main
national top stories
boston
new york blog main
alirocumab
alnylam pharmaceuticals
amgen
atrial fibrillation
boston scientific
cancer
cancer immunotherapy
center for medicare and medicaid services
clinical trial
clinical trials
companion diagnostic
cryterion medical
daniel o'day
evolocumab
food and drug administration
foundation medicine
foundationone cdx
foundationone heme
genentech
inclisiran
investing
medical devices
mergers & acquisitions
millipede
new york
new york top stories
novartis
osimertinib
pcsk9
pcsk9 inhibitors
What
acquire
3
×
agreed
billion
deal
adding
atrial
big
boston
brings
broad
business
cash
cholesterol
company
compound
confidence
continues
cryterion
device
didn’t
drug
fda
fibrillation
foundation
gain
genentech
heart
management
medco
medicine
medicines
momentum
morning
new
novartis
panels
pay
pays
picked
poised
Language
unset
Current search:
acquire
×
fda
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
